You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant Chemotherapy, Triple Negative Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2023

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 27, 2023

Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple

Recruiting
  • Triple Negative Breast Cancer
    • New Haven, Connecticut
    • +2 more
    Jan 4, 2023

    Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Dec 28, 2022

    ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

    Recruiting
    • Breast Cancer Female
    • +4 more
      • Ho Chi Minh City, Vietnam
      • +1 more
      Oct 16, 2023

      Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)

      Recruiting
      • Triple Negative Breast Cancer
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 19, 2022

      Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

      Not yet recruiting
      • Breast Neoplasm
      • (no location specified)
      May 8, 2023

      BRCA and NACT in TNBC Patients

      Completed
      • Triple-Negative Breast Cancer
      • BRCA1/2 genetic testing
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Feb 20, 2023

      Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

      Active, not recruiting
      Has Results
      • Breast Cancer
      • +3 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Nov 10, 2022

      Triple Negative Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (P10s-PADRE with MONTANIDE™ ISA 51 VG +

      Active, not recruiting
      • Triple Negative Breast Cancer
      • Breast Neoplasms
      • P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel
      • Doxorubicin + Cyclophosphamide + Paclitaxel
      • Fayetteville, Arkansas
      • +1 more
      Aug 18, 2022

      Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Jul 6, 2022

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

      Not yet recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +3 more
      • Pembrolizumab
      • +5 more
      • (no location specified)
      Apr 12, 2023

      Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • +7 more
      • (no location specified)
      Aug 1, 2022

      Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial (Toripalimab, Epirubicin, High Intensity Focused Ultrasoun)

      Not yet recruiting
      • Breast Cancer
      • TNBC - Triple-Negative Breast Cancer
      • (no location specified)
      Aug 5, 2022

      Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

      Active, not recruiting
      • Triple Negative Breast Cancer
      • London, United Kingdom
        Barts Health NHS Trust
      Aug 10, 2022

      Triple-Negative Breast Cancer Trial in Guangzhou (DCb (docetaxel/carboplatin) versus EC followed by D

      Completed
      • Triple-Negative Breast Cancer
      • DCb (docetaxel/carboplatin) versus EC followed by D (epirubicin/cyclophosphamide followed by docetaxe)
      • Guangzhou, Guangdong, China
        Guangdong General Hospital
      Aug 27, 2022

      Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-

      Terminated
      Has Results
      • Breast Cancer
      • Triple Negative Breast Cancer
      • Sodium (Na) Magnetic Resonance Imaging (MRI)
      • Dynamic Contrast- Enhanced (DCE) MRI
      • New York, New York
        NYU Langone Health
      Aug 1, 2022

      Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

      Active, not recruiting
      • Anatomic Stage IIB Breast Cancer AJCC v8
      • +19 more
      • Gilbert, Arizona
      • +4 more
      Dec 6, 2022

      Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)

      Active, not recruiting
      • Triple Negative Breast Cancer
      • HER2-positive Breast Cancer
      • exosome and ctDNA evaluation
      • Seoul, Korea, Republic of
        Ji-Yeon Kim
      Jul 13, 2023

      Triple Negative Breast Cancer Trial in Shanghai (Gemcitabine, Cisplatin)

      Active, not recruiting
      • Triple Negative Breast Cancer
      • Shanghai, Shanghai, China
        Cancer Hospital/ Institute, Fudan University
      Jul 19, 2022

      Triple Negative Breast Cancer Trial in Shanghai (Camrelizumab Plus Chemotherapy, +chemo)

      Recruiting
      • Triple Negative Breast Cancer
      • Camrelizumab Plus Chemotherapy
      • placebo+chemotherapy
      • Shanghai, China
        Fudan University Cancer Hospital
      Feb 9, 2022

      Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)

      Active, not recruiting
      • Breast Cancer
      • +2 more
      • Charleroi, Hainaut, Belgium
      • +3 more
      Aug 2, 2022